| Acne |
1 |
1 |
| Patient Safety |
0 |
0.9 |
| Isotretinoin |
0 |
0.99 |
| Rosacea |
0 |
0.72 |
| Pregnancy |
0 |
0.56 |
| Drug and Treatment Safety |
0 |
0.98 |
| Risk Evaluation and Mitigation Strategies |
0 |
0.32 |
| Skin and Soft Tissue Infection |
0 |
0.28 |
| Pediatric Dermatology |
0 |
0.97 |
| Revenue and Practice Management |
0 |
0.24 |
| Child |
0 |
0.19 |
| Exercise |
0 |
0.19 |
| Ophthalmic |
0 |
0.19 |
| Risk Management |
0 |
0.19 |
| Transgender |
0 |
0.19 |
| Social Determinants of Health |
0 |
0.14 |